Eli Lilly Ceo Says Medicare Coverage of Obesity Drugs Could 'change the Game' for Upcoming Pill Launch
The pharmaceutical industry has been abuzz with excitement over the upcoming launch of Eli Lilly's new obesity drug, and the company's CEO has just given a major reason for the optimism. In a recent interview with CNBC, David Ricks, the CEO of Eli Lilly, expressed his confidence that Medicare covera...
